Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06605625
Vaccine Responses in Cancer
Sponsor: Abramson Cancer Center at Penn Medicine
View on ClinicalTrials.gov
Summary
The investigators are conducting a prospective unblinded study of individuals diagnosed with cancer who will receive one or more of the following: influenza, SARS-CoV2 and shingles.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
250
Start Date
2022-11-04
Completion Date
2028-10
Last Updated
2025-10-28
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
Influenza vaccination
one annual dose of inactivated influenza vaccine
BIOLOGICAL
SARS-CoV-2 vaccine
dose of SARS CoV2 vaccine
BIOLOGICAL
Zoster Vaccine Recombinant
first and/or second vaccination for shingles (Herpes zoster)
Locations (1)
University of Pennsylvania
Philadelphia, Pennsylvania, United States